As of 2024-12-14, the Fair Value of Oncopeptides AB (ONCO.ST) is -6.68 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.54 SEK, the upside of Oncopeptides AB is -533.99%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -740.71 | -1,594.69 | -1,430.32 | -337.95 | -249.11 | -870.56 |
| YoY growth | -80.17% | -115.29% | 10.31% | 76.37% | 26.29% | -16.50% |
| Market Cap (mil) | 325.35 |
| P/E | |
| Forward P/E |
| EPS | -1.34 |
| Avg earnings growth rate | -16.50% |
| TTM earnings | -282.39 |